Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Who is novosanis
Latest news
February 4 marks World Cancer Day
4/02/2019
Today, 4 February, is #worldcancerday. Cervical cancer is one of the most preventable forms of cancer if it’s detected early. HPV urine testing can offer a solution for screening next to monitoring the impact of HPV vaccination.
Upcoming event
ECCMID 2019
Amsterdam, NL
We're excited to attend the 29th European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Amsterdam, Netherlands, from 13 - 16 April 2019. Hope to see you there!
Events
Regulatory
Team
News